Aspire Biosciences
Rare-disease partnering events and a searchable platform matching patient organisations with drug development companies
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Aspire Biosciences
Aspire Biosciences develops treatments for unaddressed and rare diseases by connecting patient organisations with drug development companies. Its Systematic Serendipity approach combines partnering events, a searchable database and AI-assisted matching to identify relevant drug-development assets and support partnerships.
Its participants include rare-disease patient groups, pharmaceutical and biotech companies, researchers and clinical or scientific advisors. The company is based in Cambridge and was founded in 2022.
Product: Partnering events, a searchable database and AI-assisted matching that connect rare-disease patient organisations with drug development companies.
Jobs at Aspire Biosciences
Leadership
- Ron Jortner · Our founderSource: company website
More biotech & pharma companies
Aspire Laboratories
Contract analytical and microbiological testing for pharmaceutical, cosmetics, veterinary, healthcare and medical-device companiesNew on EvolcAspire Pharma
Specialty and niche generic medicines for patients, healthcare professionals and health systems in the UK and international marketsRemote-friendlyAstute Healthcare
Wholesale distributor of medicines and FMCG health and personal care products to pharmacies, retailers and hospitals in the UKAsymchem
Small-molecule drug development and GMP manufacturing services for biotech and pharmaceutical companies worldwideAutolus
Develops engineered T-cell therapies for patients with cancer and autoimmune diseasesRemote-friendlyAutomata
Lab automation hardware and software for life science labs, including workflow orchestration and configurable lab benchesRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.